138 related articles for article (PubMed ID: 12899737)
1. Glucuronidation enzymes, genes and psychiatry.
de Leon J
Int J Neuropsychopharmacol; 2003 Mar; 6(1):57-72. PubMed ID: 12899737
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of human UDP-glucuronosyltransferase genes.
Hu DG; Meech R; McKinnon RA; Mackenzie PI
Drug Metab Rev; 2014 Nov; 46(4):421-58. PubMed ID: 25336387
[TBL] [Abstract][Full Text] [Related]
3. UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver.
Court MH; Hao Q; Krishnaswamy S; Bekaii-Saab T; Al-Rohaimi A; von Moltke LL; Greenblatt DJ
J Pharmacol Exp Ther; 2004 Aug; 310(2):656-65. PubMed ID: 15044558
[TBL] [Abstract][Full Text] [Related]
4. UDP-glucuronosyltransferases.
King CD; Rios GR; Green MD; Tephly TR
Curr Drug Metab; 2000 Sep; 1(2):143-61. PubMed ID: 11465080
[TBL] [Abstract][Full Text] [Related]
5. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
Turgeon D; Carrier JS; Lévesque E; Hum DW; Bélanger A
Endocrinology; 2001 Feb; 142(2):778-87. PubMed ID: 11159850
[TBL] [Abstract][Full Text] [Related]
6. UDP-glucuronosyltransferases and clinical drug-drug interactions.
Kiang TK; Ensom MH; Chang TK
Pharmacol Ther; 2005 Apr; 106(1):97-132. PubMed ID: 15781124
[TBL] [Abstract][Full Text] [Related]
7. Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.
Strassburg CP; Kneip S; Topp J; Obermayer-Straub P; Barut A; Tukey RH; Manns MP
J Biol Chem; 2000 Nov; 275(46):36164-71. PubMed ID: 10748067
[TBL] [Abstract][Full Text] [Related]
8. Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines.
Nakamura A; Nakajima M; Yamanaka H; Fujiwara R; Yokoi T
Drug Metab Dispos; 2008 Aug; 36(8):1461-4. PubMed ID: 18480185
[TBL] [Abstract][Full Text] [Related]
9. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.
Strassburg CP; Strassburg A; Nguyen N; Li Q; Manns MP; Tukey RH
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):489-98. PubMed ID: 10024527
[TBL] [Abstract][Full Text] [Related]
10. The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7.
Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Miners JO
Drug Metab Dispos; 2007 Mar; 35(3):363-70. PubMed ID: 17151189
[TBL] [Abstract][Full Text] [Related]
11. Construction and Verification of Physiologically Based Pharmacokinetic Models for Four Drugs Majorly Cleared by Glucuronidation: Lorazepam, Oxazepam, Naloxone, and Zidovudine.
Docci L; Umehara K; Krähenbühl S; Fowler S; Parrott N
AAPS J; 2020 Oct; 22(6):128. PubMed ID: 33033903
[TBL] [Abstract][Full Text] [Related]
12. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
Kerdpin O; Mackenzie PI; Bowalgaha K; Finel M; Miners JO
Drug Metab Dispos; 2009 Sep; 37(9):1948-55. PubMed ID: 19487247
[TBL] [Abstract][Full Text] [Related]
13. Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases.
Court MH
Methods Enzymol; 2005; 400():104-16. PubMed ID: 16399346
[TBL] [Abstract][Full Text] [Related]
14. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.
Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG
Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes.
Guillemette C
Pharmacogenomics J; 2003; 3(3):136-58. PubMed ID: 12815363
[TBL] [Abstract][Full Text] [Related]
16. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
17. Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential.
Margaillan G; Rouleau M; Klein K; Fallon JK; Caron P; Villeneuve L; Smith PC; Zanger UM; Guillemette C
Drug Metab Dispos; 2015 Sep; 43(9):1331-5. PubMed ID: 26076694
[TBL] [Abstract][Full Text] [Related]
18. Distribution of uridine diphosphate-glucuronosyltransferase (UGT) expression and activity in cynomolgus monkey tissues: evidence for differential expression of steroid-conjugating UGT enzymes in steroid target tissues.
Albert C; Barbier O; Vallée M; Beaudry G; Bélanger A; Hum DW
Endocrinology; 2000 Jul; 141(7):2472-80. PubMed ID: 10875248
[TBL] [Abstract][Full Text] [Related]
19. Glucuronidation in humans. Pharmacogenetic and developmental aspects.
de Wildt SN; Kearns GL; Leeder JS; van den Anker JN
Clin Pharmacokinet; 1999 Jun; 36(6):439-52. PubMed ID: 10427468
[TBL] [Abstract][Full Text] [Related]
20. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
Tachibana M; Tanaka M; Masubuchi Y; Horie T
Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
